Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 112 | 209 | 82 | 126 | 157 |
| Cost of Goods | 171 | 280 | 197 | 161 | 181 |
| Gross Profit | -59 | -71 | -115 | -35 | -24 |
| Operating Expenses | 20,690 | 10,359 | 7,853 | 6,345 | 5,229 |
| Operating Income | -20,578 | -10,150 | -7,771 | -6,219 | -5,072 |
| Other Income | 982 | 987 | 823 | 267 | 240 |
| Pre-tax Income | -19,596 | -9,163 | -6,948 | -5,952 | -4,832 |
| Net Income Continuous | -19,596 | -9,163 | -6,948 | -5,952 | -4,832 |
| Net Income | $-19,596 | $-9,163 | $-6,948 | $-5,952 | $-4,832 |
| EPS Basic Total Ops | -0.51 | -0.25 | -0.19 | -0.19 | -0.15 |
| EPS Basic Continuous Ops | -0.51 | -0.25 | -0.19 | -0.19 | -0.15 |
| EPS Diluted Total Ops | -0.51 | -0.25 | -0.19 | -0.19 | -0.15 |
| EPS Diluted Continuous Ops | -0.51 | -0.25 | -0.19 | -0.19 | -0.15 |
| EBITDA(a) | $-20,526 | $-10,096 | $-7,721 | $-6,173 | $-5,032 |